ASPIRIN

Product NDC: 49483-011
11-digit product format: 494830011
Labeler code: 49483
Product ID: 49483-011_0acac93d-0f05-0658-e063-6294a90a83c3
Type: HUMAN OTC DRUG
Nonproprietary name: ASPIRIN
Dosage form: TABLET, COATED
Route: ORAL
Labeler: TIME CAP LABS INC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2014-04-02
Substance: ASPIRIN
Active strength: 325 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 8 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49483-011-00	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49483-011-10	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49483-011-01	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	49483-011-00	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	49483-011-10	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	49483-011-01	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ASPIRIN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	325 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
212033	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
fe12519c-3e5f-4592-bd34-2d6b81b981f4	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
49483-011-00	2021-11-22	Aspirin 325 mg tablets
49483-011-01	2021-11-22	Aspirin 325 mg tablets
49483-011-10	2021-11-22	Aspirin 325 mg tablets
49483-011-00	2020-01-31	Aspirin 325 mg tablets
49483-011-01	2020-01-31	Aspirin 325 mg tablets
49483-011-10	2020-01-31	Aspirin 325 mg tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
49483-011-00	ASPIRIN	100000 in 1 CARTON	TABLET, COATED	100000	4
49483-011-01	ASPIRIN	100 in 1 BOTTLE, PLASTIC	TABLET, COATED	100	4
49483-011-10	ASPIRIN	1000 in 1 BOTTLE, PLASTIC	TABLET, COATED	1000	4
49483-011-31	ASPIRIN	300 in 1 BOTTLE	TABLET, COATED	300	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49483-011-01	EA - Each	49483-011	1a8b4a59-e054-44a3-8315-d49574cf89e3	1	2012-07-24
49483-011-10	EA - Each	49483-011	d996d20c-42cd-41a2-a29a-679d7f395c76	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN TABLET [APOTHECA, INC]	2
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN TABLET [APOTHECA, INC]	2
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN TABLET [APOTHECA, INC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ASPIRIN TABLET [APOTHECA, INC]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN TABLET [APOTHECA, INC]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	ASPIRIN TABLET [APOTHECA, INC]	2
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN TABLET [APOTHECA, INC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN TABLET [APOTHECA, INC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	2
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN TABLET, COATED [SAFECOR HEALTH, LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN TABLET, COATED [LIBERTY PHARMACEUTICALS, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49483-011	ASPIRIN TABLET, COATED [TIME CAP LABS INC]	4	Current NDC, Legacy NDC, 4 package rows	20231123_fe12519c-3e5f-4592-bd34-2d6b81b981f4.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 79 · 1,576 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aspirin	ASPIRIN	United Natural Foods, Inc. dba UNFI	19c7f832-d7ec-4dcc-8aa4-f4cbf64c9ff6	2026-07-02	Warnings	Exact identifier application number: M013
pain relief EXTRA STRENGTH	ACETAMINOPHEN	Meijer Distribution, Inc.	ae84eb7e-a70b-4311-b2dc-ad153047a516	2026-07-01	Warnings	Exact identifier application number: M013
Aspirin 325 mg	ASPIRIN	Hi-Tech Nutraceuticals, LLC	b3426a9a-ea99-da30-e053-2995a90a1e4b	2026-07-01	Warnings	Exact identifier application number: M013
Headache Relief Extra Strength	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	Salado Sales, Inc.	ca21d576-be3c-495d-9dbd-ed514bf65da7	2026-07-01	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Meijer Distribution Inc	4e08a7cb-3894-84c3-e063-6394a90a0b42	2026-06-30	Warnings	Exact identifier application number: M013
Headache Relief Extra Strength	ACETAMINOPHEN, ASPIRIN AND CAFFEINE	Wal-Mart Stores Inc	9b1201af-c802-4e19-b192-bbbf34367db4	2026-06-30	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN	P & L Development, LLC	fc841cba-8f4f-407b-97de-0422977515bd	2026-06-30	Warnings	Exact identifier application number: M013
Headache Relief	ACETAMINOPHEN, ASPIRIN, CAFFEINE	United Natural Foods, Inc. dba UNFI	b6ff2b34-51ee-41bc-8b7d-7520ade0bf36	2026-06-30	Warnings	Exact identifier application number: M013
Medline	ASPIRIN	Medline Industries, LP	4b0c569a-ed7a-e104-e063-6394a90a6d54	2026-06-29	Warnings	Exact identifier application number: M013
Pain Reliever PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	WALMART INC.	e50b3f60-b827-426c-8e78-8447c89130fe	2026-06-29	Warnings	Exact identifier application number: M013
Acetaminophen PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	Chain Drug Marketing Association, Inc.	e58417f4-3575-4433-ac2e-b7bf9fe8ba10	2026-06-29	Warnings	Exact identifier application number: M013
Dr Kids Pain and Fever	ACETAMINOPHEN	CalmCo LLC	5534a784-a7b1-5599-e063-6294a90a7961	2026-06-27	Warnings	Exact identifier application number: M013
TYLENOL Extra Strength	ACETAMINOPHEN	Select Consumer Group LLC	529d3a51-a248-7c02-e063-6294a90a10ae	2026-06-27	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	Sportpharm LLC	830ffcaa-7ff8-4732-bc84-6a8c5e78722d	2026-06-25	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Strategic Sourcing Services LLC	ea2ef485-429e-4c63-ba7b-0a6b32892ad2	2026-06-25	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Chain Drug Marketing Association, Inc.	055d8420-c189-4a9e-acdc-21627935c8eb	2026-06-25	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Topco Associates, LLC	5f32cf74-dbea-496c-ba23-2040ea354f40	2026-06-25	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Salado Sales, Inc.	cf3139a5-e36e-48e3-bb6c-e102b0cec555	2026-06-25	Warnings	Exact identifier application number: M013
Pain Relief Aspirin	ASPIRIN	Rite Aid Corporation	bd69d3d2-5d38-47c6-98a6-124f7a43b8b0	2026-06-25	Warnings	Exact identifier application number: M013
Aspirin Regular Strength	ASPIRIN	Walgreen Company	0b27c0fd-7ea8-4588-9169-5ad4e8df77ef	2026-06-25	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
212033	aspirin 325 MG Oral Tablet	PSN	fe12519c-3e5f-4592-bd34-2d6b81b981f4	4
212033	aspirin 325 MG Oral Tablet	SCD	fe12519c-3e5f-4592-bd34-2d6b81b981f4	4
212033	ASA 325 MG Oral Tablet	SY	fe12519c-3e5f-4592-bd34-2d6b81b981f4	4
212033	aspirin 325 MG Oral Tablet	PSN	01cdc525-f51f-4779-9e3b-01a35dd3bcac	2
212033	aspirin 325 MG Oral Tablet	SCD	01cdc525-f51f-4779-9e3b-01a35dd3bcac	2
212033	ASA 325 MG Oral Tablet	SY	01cdc525-f51f-4779-9e3b-01a35dd3bcac	2
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	2d368df5-c176-435d-b8b9-a171f972fd14	1
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	2d368df5-c176-435d-b8b9-a171f972fd14	1
198467	ASA 325 MG Delayed Release Oral Tablet	SY	2d368df5-c176-435d-b8b9-a171f972fd14	1
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	2d368df5-c176-435d-b8b9-a171f972fd14	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
49483-011-00	49483001100	100000 TABLET, COATED in 1 CARTON (49483-011-00)	2014-04-02	0000-00-00	No	No	Current
49483-011-01	49483001101	100 TABLET, COATED in 1 BOTTLE, PLASTIC (49483-011-01)	2014-04-02	0000-00-00	No	No	Current
49483-011-10	49483001110	1000 TABLET, COATED in 1 BOTTLE, PLASTIC (49483-011-10)	2014-04-02	0000-00-00	No	No	Current
49483-011-31	49483001131	300 TABLET, COATED in 1 BOTTLE (49483-011-31)	2023-11-02		No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aspirin 325 mg tablets	TIME CAP LABS INC	2023-11-22	HUMAN OTC DRUG LABEL	4
ASPIRIN - REMEDYREPACK INC.	REMEDYREPACK INC.	2019-02-11	HUMAN OTC DRUG LABEL	3
ASPIRIN - Safecor Health, LLC	Safecor Health, LLC	2014-04-02	HUMAN OTC DRUG LABEL	1
ASPIRIN TABLETS USP, 325 MG	Apotheca, Inc	2013-10-11	HUMAN OTC DRUG LABEL	2
ASPIRIN FOR TIME CAP	Liberty Pharmaceuticals, Inc.	2013-09-05	HUMAN OTC DRUG LABEL	1